 | • レポートコード：QY2203B02706 • 出版社/出版日：QYResearch / 2022年3月11日 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のケトロラク注射液の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にケトロラク注射液の世界市場のxxx％を占める「15mg/ml」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のケトロラク注射液の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのケトロラク注射液市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのケトロラク注射液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ケトロラク注射液のグローバル主要メーカーには、Pfizer、Fresenius Kabi、Fosun Pharma (Gland Pharma)、Sagent Pharmaceuticals、Hikma、Lunan Pharma、Alvogen、Chengdu Brilliant Pharmaceuticals、Athenex、Sichuan Medcalo、Julphar Bangladesh Ltd.、Yung Shin Pharm、Tianjin Chase Sun Pharmaceutical、ZISKA Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ケトロラク注射液市場は、種類と用途によって区分されます。世界のケトロラク注射液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 15mg/ml、30mg/ml 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ケトロラク注射液製品概要 - 種類別市場（15mg/ml、30mg/ml ） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のケトロラク注射液販売量予測2017-2028 - 世界のケトロラク注射液売上予測2017-2028 - ケトロラク注射液の地域別販売量 - ケトロラク注射液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ケトロラク注射液販売量 - 主要メーカー別ケトロラク注射液売上 - 主要メーカー別ケトロラク注射液価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（15mg/ml、30mg/ml ） - ケトロラク注射液の種類別販売量 - ケトロラク注射液の種類別売上 - ケトロラク注射液の種類別価格 ・用途別市場規模（病院、診療所、その他） - ケトロラク注射液の用途別販売量 - ケトロラク注射液の用途別売上 - ケトロラク注射液の用途別価格 ・北米市場 - 北米のケトロラク注射液市場規模（種類別、用途別） - 主要国別のケトロラク注射液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのケトロラク注射液市場規模（種類別、用途別） - 主要国別のケトロラク注射液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のケトロラク注射液市場規模（種類別、用途別） - 主要国別のケトロラク注射液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のケトロラク注射液市場規模（種類別、用途別） - 主要国別のケトロラク注射液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのケトロラク注射液市場規模（種類別、用途別） - 主要国別のケトロラク注射液市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Fresenius Kabi、Fosun Pharma (Gland Pharma)、Sagent Pharmaceuticals、Hikma、Lunan Pharma、Alvogen、Chengdu Brilliant Pharmaceuticals、Athenex、Sichuan Medcalo、Julphar Bangladesh Ltd.、Yung Shin Pharm、Tianjin Chase Sun Pharmaceutical、ZISKA Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ケトロラク注射液の産業チェーン分析 - ケトロラク注射液の原材料 - ケトロラク注射液の生産プロセス - ケトロラク注射液の販売及びマーケティング - ケトロラク注射液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ケトロラク注射液の産業動向 - ケトロラク注射液のマーケットドライバー - ケトロラク注射液の課題 - ケトロラク注射液の阻害要因 ・主な調査結果 |
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
Market Analysis and Insights: Global Ketorolac Injection Market
Due to the COVID-19 pandemic, the global Ketorolac Injection market size is estimated to be worth US$ 959.9 million in 2022 and is forecast to a readjusted size of US$ 1125.6 million by 2028 with a CAGR of 2.7% during the review period. Fully considering the economic change by this health crisis, 15mg/ml accounting for % of the Ketorolac Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Global Ketorolac Injection Scope and Segment
Ketorolac Injection market is segmented by Concentration and by Application. Players, stakeholders, and other participants in the global Ketorolac Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Concentration and by Application for the period 2017-2028.
Segment by Concentration
15mg/ml
30mg/ml
Segment by Application
Hospital
Clinics
Others
By Company
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Ketorolac Injection Product Introduction
1.2 Market by Concentration
1.2.1 Global Ketorolac Injection Market Size Growth Rate by Concentration, 2017 VS 2021 VS 2028
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Market by Application
1.3.1 Global Ketorolac Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ketorolac Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Ketorolac Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Ketorolac Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ketorolac Injection Sales by Region
2.4.1 Global Ketorolac Injection Sales by Region (2017-2022)
2.4.2 Global Sales Ketorolac Injection by Region (2023-2028)
2.5 Global Ketorolac Injection Revenue by Region
2.5.1 Global Ketorolac Injection Revenue by Region (2017-2022)
2.5.2 Global Ketorolac Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ketorolac Injection Sales by Manufacturers
3.1.1 Global Top Ketorolac Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Ketorolac Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ketorolac Injection in 2021
3.2 Global Ketorolac Injection Revenue by Manufacturers
3.2.1 Global Ketorolac Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ketorolac Injection Revenue in 2021
3.3 Global Ketorolac Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ketorolac Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Concentration
4.1 Global Ketorolac Injection Sales by Concentration
4.1.1 Global Ketorolac Injection Historical Sales by Concentration (2017-2022)
4.1.2 Global Ketorolac Injection Forecasted Sales by Concentration (2023-2028)
4.1.3 Global Ketorolac Injection Sales Market Share by Concentration (2017-2028)
4.2 Global Ketorolac Injection Revenue by Concentration
4.2.1 Global Ketorolac Injection Historical Revenue by Concentration (2017-2022)
4.2.2 Global Ketorolac Injection Forecasted Revenue by Concentration (2023-2028)
4.2.3 Global Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
4.3 Global Ketorolac Injection Price by Concentration
4.3.1 Global Ketorolac Injection Price by Concentration (2017-2022)
4.3.2 Global Ketorolac Injection Price Forecast by Concentration (2023-2028)
5 Market Size by Application
5.1 Global Ketorolac Injection Sales by Application
5.1.1 Global Ketorolac Injection Historical Sales by Application (2017-2022)
5.1.2 Global Ketorolac Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Ketorolac Injection Sales Market Share by Application (2017-2028)
5.2 Global Ketorolac Injection Revenue by Application
5.2.1 Global Ketorolac Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Ketorolac Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
5.3 Global Ketorolac Injection Price by Application
5.3.1 Global Ketorolac Injection Price by Application (2017-2022)
5.3.2 Global Ketorolac Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ketorolac Injection Market Size by Concentration
6.1.1 North America Ketorolac Injection Sales by Concentration (2017-2028)
6.1.2 North America Ketorolac Injection Revenue by Concentration (2017-2028)
6.2 North America Ketorolac Injection Market Size by Application
6.2.1 North America Ketorolac Injection Sales by Application (2017-2028)
6.2.2 North America Ketorolac Injection Revenue by Application (2017-2028)
6.3 North America Ketorolac Injection Market Size by Country
6.3.1 North America Ketorolac Injection Sales by Country (2017-2028)
6.3.2 North America Ketorolac Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ketorolac Injection Market Size by Concentration
7.1.1 Europe Ketorolac Injection Sales by Concentration (2017-2028)
7.1.2 Europe Ketorolac Injection Revenue by Concentration (2017-2028)
7.2 Europe Ketorolac Injection Market Size by Application
7.2.1 Europe Ketorolac Injection Sales by Application (2017-2028)
7.2.2 Europe Ketorolac Injection Revenue by Application (2017-2028)
7.3 Europe Ketorolac Injection Market Size by Country
7.3.1 Europe Ketorolac Injection Sales by Country (2017-2028)
7.3.2 Europe Ketorolac Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ketorolac Injection Market Size by Concentration
8.1.1 Asia Pacific Ketorolac Injection Sales by Concentration (2017-2028)
8.1.2 Asia Pacific Ketorolac Injection Revenue by Concentration (2017-2028)
8.2 Asia Pacific Ketorolac Injection Market Size by Application
8.2.1 Asia Pacific Ketorolac Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Ketorolac Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Ketorolac Injection Market Size by Region
8.3.1 Asia Pacific Ketorolac Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Ketorolac Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ketorolac Injection Market Size by Concentration
9.1.1 Latin America Ketorolac Injection Sales by Concentration (2017-2028)
9.1.2 Latin America Ketorolac Injection Revenue by Concentration (2017-2028)
9.2 Latin America Ketorolac Injection Market Size by Application
9.2.1 Latin America Ketorolac Injection Sales by Application (2017-2028)
9.2.2 Latin America Ketorolac Injection Revenue by Application (2017-2028)
9.3 Latin America Ketorolac Injection Market Size by Country
9.3.1 Latin America Ketorolac Injection Sales by Country (2017-2028)
9.3.2 Latin America Ketorolac Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ketorolac Injection Market Size by Concentration
10.1.1 Middle East and Africa Ketorolac Injection Sales by Concentration (2017-2028)
10.1.2 Middle East and Africa Ketorolac Injection Revenue by Concentration (2017-2028)
10.2 Middle East and Africa Ketorolac Injection Market Size by Application
10.2.1 Middle East and Africa Ketorolac Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ketorolac Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Ketorolac Injection Market Size by Country
10.3.1 Middle East and Africa Ketorolac Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ketorolac Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Fresenius Kabi Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius Kabi Recent Developments
11.3 Fosun Pharma (Gland Pharma)
11.3.1 Fosun Pharma (Gland Pharma) Corporation Information
11.3.2 Fosun Pharma (Gland Pharma) Overview
11.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fosun Pharma (Gland Pharma) Recent Developments
11.4 Sagent Pharmaceuticals
11.4.1 Sagent Pharmaceuticals Corporation Information
11.4.2 Sagent Pharmaceuticals Overview
11.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sagent Pharmaceuticals Recent Developments
11.5 Hikma
11.5.1 Hikma Corporation Information
11.5.2 Hikma Overview
11.5.3 Hikma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hikma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Recent Developments
11.6 Lunan Pharma
11.6.1 Lunan Pharma Corporation Information
11.6.2 Lunan Pharma Overview
11.6.3 Lunan Pharma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lunan Pharma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lunan Pharma Recent Developments
11.7 Alvogen
11.7.1 Alvogen Corporation Information
11.7.2 Alvogen Overview
11.7.3 Alvogen Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alvogen Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alvogen Recent Developments
11.8 Chengdu Brilliant Pharmaceuticals
11.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information
11.8.2 Chengdu Brilliant Pharmaceuticals Overview
11.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
11.9 Athenex
11.9.1 Athenex Corporation Information
11.9.2 Athenex Overview
11.9.3 Athenex Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Athenex Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Athenex Recent Developments
11.10 Sichuan Medcalo
11.10.1 Sichuan Medcalo Corporation Information
11.10.2 Sichuan Medcalo Overview
11.10.3 Sichuan Medcalo Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sichuan Medcalo Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sichuan Medcalo Recent Developments
11.11 Julphar Bangladesh Ltd.
11.11.1 Julphar Bangladesh Ltd. Corporation Information
11.11.2 Julphar Bangladesh Ltd. Overview
11.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Julphar Bangladesh Ltd. Recent Developments
11.12 Yung Shin Pharm
11.12.1 Yung Shin Pharm Corporation Information
11.12.2 Yung Shin Pharm Overview
11.12.3 Yung Shin Pharm Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Yung Shin Pharm Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Yung Shin Pharm Recent Developments
11.13 Tianjin Chase Sun Pharmaceutical
11.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information
11.13.2 Tianjin Chase Sun Pharmaceutical Overview
11.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
11.14 ZISKA Pharmaceuticals
11.14.1 ZISKA Pharmaceuticals Corporation Information
11.14.2 ZISKA Pharmaceuticals Overview
11.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ZISKA Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ketorolac Injection Industry Chain Analysis
12.2 Ketorolac Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ketorolac Injection Production Mode & Process
12.4 Ketorolac Injection Sales and Marketing
12.4.1 Ketorolac Injection Sales Channels
12.4.2 Ketorolac Injection Distributors
12.5 Ketorolac Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ketorolac Injection Industry Trends
13.2 Ketorolac Injection Market Drivers
13.3 Ketorolac Injection Market Challenges
13.4 Ketorolac Injection Market Restraints
14 Key Findings in The Global Ketorolac Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Ketorolac Injection Market Size Growth Rate by Concentration, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 15mg/ml
Table 3. Major Manufacturers of 30mg/ml
Table 4. Global Ketorolac Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Ketorolac Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Ketorolac Injection Sales by Region (2017-2022) & (K Units)
Table 7. Global Ketorolac Injection Sales Market Share by Region (2017-2022)
Table 8. Global Ketorolac Injection Sales by Region (2023-2028) & (K Units)
Table 9. Global Ketorolac Injection Sales Market Share by Region (2023-2028)
Table 10. Global Ketorolac Injection Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Ketorolac Injection Revenue Market Share by Region (2017-2022)
Table 12. Global Ketorolac Injection Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Ketorolac Injection Revenue Market Share by Region (2023-2028)
Table 14. Global Ketorolac Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Ketorolac Injection Sales Share by Manufacturers (2017-2022)
Table 16. Global Ketorolac Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Ketorolac Injection Revenue Share by Manufacturers (2017-2022)
Table 18. Ketorolac Injection Price by Manufacturers (2017-2022) &(US$/K Units)
Table 19. Global Ketorolac Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2021)
Table 21. Ketorolac Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Ketorolac Injection Product Offered
Table 23. Date of Manufacturers Enter into Ketorolac Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 26. Global Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 27. Global Ketorolac Injection Sales Share by Concentration (2017-2022)
Table 28. Global Ketorolac Injection Sales Share by Concentration (2023-2028)
Table 29. Global Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 30. Global Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 31. Global Ketorolac Injection Revenue Share by Concentration (2017-2022)
Table 32. Global Ketorolac Injection Revenue Share by Concentration (2023-2028)
Table 33. Ketorolac Injection Price by Concentration (2017-2022) & (US$/K Units)
Table 34. Global Ketorolac Injection Price Forecast by Concentration (2023-2028) & (US$/K Units)
Table 35. Global Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 36. Global Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 37. Global Ketorolac Injection Sales Share by Application (2017-2022)
Table 38. Global Ketorolac Injection Sales Share by Application (2023-2028)
Table 39. Global Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Ketorolac Injection Revenue Share by Application (2017-2022)
Table 42. Global Ketorolac Injection Revenue Share by Application (2023-2028)
Table 43. Ketorolac Injection Price by Application (2017-2022) & (US$/K Units)
Table 44. Global Ketorolac Injection Price Forecast by Application (2023-2028) & (US$/K Units)
Table 45. North America Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 46. North America Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 47. North America Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 48. North America Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 49. North America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 50. North America Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 51. North America Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 54. North America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 55. North America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 58. Europe Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 59. Europe Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 60. Europe Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 61. Europe Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 62. Europe Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 63. Europe Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 66. Europe Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 67. Europe Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 70. Asia Pacific Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 71. Asia Pacific Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 72. Asia Pacific Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 73. Asia Pacific Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Ketorolac Injection Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Ketorolac Injection Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Ketorolac Injection Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Ketorolac Injection Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 82. Latin America Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 83. Latin America Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 84. Latin America Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 85. Latin America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 94. Middle East and Africa Ketorolac Injection Sales by Concentration (2023-2028) & (K Units)
Table 95. Middle East and Africa Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Ketorolac Injection Revenue by Concentration (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Ketorolac Injection Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Ketorolac Injection Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Ketorolac Injection Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 108. Pfizer Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Major Businesses
Table 112. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 113. Fresenius Kabi Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Fresenius Kabi Recent Developments
Table 115. Fosun Pharma (Gland Pharma) Corporation Information
Table 116. Fosun Pharma (Gland Pharma) Description and Major Businesses
Table 117. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 118. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Fosun Pharma (Gland Pharma) Recent Developments
Table 120. Sagent Pharmaceuticals Corporation Information
Table 121. Sagent Pharmaceuticals Description and Major Businesses
Table 122. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 123. Sagent Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sagent Pharmaceuticals Recent Developments
Table 125. Hikma Corporation Information
Table 126. Hikma Description and Major Businesses
Table 127. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 128. Hikma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Hikma Recent Developments
Table 130. Lunan Pharma Corporation Information
Table 131. Lunan Pharma Description and Major Businesses
Table 132. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 133. Lunan Pharma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Lunan Pharma Recent Developments
Table 135. Alvogen Corporation Information
Table 136. Alvogen Description and Major Businesses
Table 137. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 138. Alvogen Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Alvogen Recent Developments
Table 140. Chengdu Brilliant Pharmaceuticals Corporation Information
Table 141. Chengdu Brilliant Pharmaceuticals Description and Major Businesses
Table 142. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 143. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Chengdu Brilliant Pharmaceuticals Recent Developments
Table 145. Athenex Corporation Information
Table 146. Athenex Description and Major Businesses
Table 147. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 148. Athenex Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Athenex Recent Developments
Table 150. Sichuan Medcalo Corporation Information
Table 151. Sichuan Medcalo Description and Major Businesses
Table 152. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 153. Sichuan Medcalo Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sichuan Medcalo Recent Developments
Table 155. Julphar Bangladesh Ltd. Corporation Information
Table 156. Julphar Bangladesh Ltd. Description and Major Businesses
Table 157. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 158. Julphar Bangladesh Ltd. Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Julphar Bangladesh Ltd. Recent Developments
Table 160. Yung Shin Pharm Corporation Information
Table 161. Yung Shin Pharm Description and Major Businesses
Table 162. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 163. Yung Shin Pharm Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Yung Shin Pharm Recent Developments
Table 165. Tianjin Chase Sun Pharmaceutical Corporation Information
Table 166. Tianjin Chase Sun Pharmaceutical Description and Major Businesses
Table 167. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 168. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Tianjin Chase Sun Pharmaceutical Recent Developments
Table 170. ZISKA Pharmaceuticals Corporation Information
Table 171. ZISKA Pharmaceuticals Description and Major Businesses
Table 172. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 173. ZISKA Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ZISKA Pharmaceuticals Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Ketorolac Injection Distributors List
Table 178. Ketorolac Injection Customers List
Table 179. Ketorolac Injection Market Trends
Table 180. Ketorolac Injection Market Drivers
Table 181. Ketorolac Injection Market Challenges
Table 182. Ketorolac Injection Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Ketorolac Injection Product Picture
Figure 3. Global Ketorolac Injection Market Share by Concentration in 2021 & 2028
Figure 3. 15mg/ml Product Picture
Figure 4. 30mg/ml Product Picture
Figure 5. Global Ketorolac Injection Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Others
Figure 9. Ketorolac Injection Report Years Considered
Figure 10. Global Ketorolac Injection Sales 2017-2028 (K Units)
Figure 11. Global Ketorolac Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ketorolac Injection Revenue 2017-2028 (US$ Million)
Figure 13. Global Ketorolac Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Ketorolac Injection Sales Market Share by Region (2017-2022)
Figure 15. Global Ketorolac Injection Sales Market Share by Region (2023-2028)
Figure 16. North America Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 17. North America Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Ketorolac Injection Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Ketorolac Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Ketorolac Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Ketorolac Injection in the World: Market Share by Ketorolac Injection Revenue in 2021
Figure 28. Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 30. Global Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 31. Global Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 32. Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 33. North America Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 34. North America Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 35. North America Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 36. North America Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 37. North America Ketorolac Injection Sales Share by Country (2017-2028)
Figure 38. North America Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 39. United States Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 42. Europe Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 43. Europe Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 45. Europe Ketorolac Injection Sales Share by Country (2017-2028)
Figure 46. Europe Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 47. Germany Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 48. France Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 53. Asia Pacific Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 54. Asia Pacific Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Ketorolac Injection Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Ketorolac Injection Revenue Share by Region (2017-2028)
Figure 58. China Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 61. India Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 68. Latin America Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 69. Latin America Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 70. Latin America Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Ketorolac Injection Sales Share by Country (2017-2028)
Figure 72. Latin America Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 73. Mexico Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Ketorolac Injection Sales Market Share by Concentration (2017-2028)
Figure 77. Middle East and Africa Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
Figure 78. Middle East and Africa Ketorolac Injection Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Ketorolac Injection Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Ketorolac Injection Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Ketorolac Injection Revenue Share by Country (2017-2028)
Figure 82. Turkey Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Ketorolac Injection Revenue (2017-2028) & (US$ Million)
Figure 85. Ketorolac Injection Value Chain
Figure 86. Ketorolac Injection Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed